Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas

Clinical trial NCT05565417 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05565417
Sponsor: Immunitas Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Head and Neck Squamous Cell Carcinoma Triple Negative Breast Cancer Cutaneous Squamous Cell Carcinoma Hormone Receptor Positive Breast Carcinoma Small Bowel Cancer Esophageal Cancer Colorectal Cancer Diffuse Large B Cell Lymphoma Hodgkin Lymphoma Burkitt Lymphoma Follicular Lymphoma

Start date: 2022-11-28
Primary completion: 2026-01-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.